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Abstract 
The transport characteristics of ceftibuten, a dianionic ephem antibiotic, in rat renal and intestinal brush-border membranes were 
compared. Ceftibuten transport was mediated by two transport systems in the renal brush-border membrane and by one transport system 
in the intestinal brush-border membrane. The apparent kinetic parameters for the uptake of ceftibuten by the renal brush-border membrane 
vesicles, respectively, were: Km,, Kin2 values of 26 and 1946 /xM and Vmax,, Vm~x " values of 105 and 1400 pmol/mg protein per 30 s. 
The apparent kinetic parameters for the uptake by the intestinal brush-border membrane vesicles were: K m of 425 /xM and Vn,~x of 1701 
pmol/mg protein per 30 s. In the renal brush-border membrane, L-AIa-L-Pro was partially competitive and competitive inhibitor for the 
uptake by the high and low affinity systems, respectively. However, L-AIa-L-Pro was a non-competitive inhibitor for the uptake by the 
intestinal brush-border membrane vesicles. L-Carnosine was a specific and competitive inhibitor for the high affinity system in the renal 
brush-border membrane, while it had no effect on the low affinity system of the kidney or on the transport system of the intestine. It was 
concluded that the transport characteristics of ceftibuten in the renal and intestinal brush-border membranes are similar in some aspects 
but they are not identical. 
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1. Introduction 
Ceftibuten, a water-soluble dianionic cephem antibiotic, 
possesses good pharmacokinetic properties which include 
a high oral bioavailabil ity and a relatively long elimination 
half-life when compared with other cephem antibiotics [1]. 
These favorable properties have attracted several re- 
searchers to investigate the transport mechanism of this 
compound across biomembranes at the molecular level. 
Previous studies [2-5] on the transport mechanism of 
ceftibuten across intestinal brush-border membrane have 
shown that ceftibuten, in spite of being a strong dianionic 
compound, does share a common transport mechanism 
with oligopeptides. Moreover, we have recently examined 
the transport mechanism of this compound in the renal 
proximal tubular brush-border membrane [6] and, simi- 
larly, we have found that the reabsorption of this com- 
pound from the lumenal side is mediated by the oligopep- 
tide transporter(s) without any interference from the anion 
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transporters. However, during our investigations we have 
noticed that the transport mechanisms of ceftibuten in the 
renal brush-border membrane were not always identical to 
those in the intestinal brush-border membrane and some 
differences (such as substrate specificity) could be found 
[6,1 i]. Therefore, in order to gain additional details on the 
differences of the transport systems of ceftibuten in these 
two types of biological membranes, we further investigated 
and compared the transport characteristics of this com- 
pound using brush-border membrane vesicles isolated from 
renal proximal tubules and small intestine of rat. This 
study will increase the knowledge about the transport 
mechanisms of not only ceftibuten but also other peptide- 
like compounds across the brush-border membranes. 
2. Materials and methods 
2.1. Materials 
Ceftibuten was kindly donated by Shionogi (Osaka, 
Japan). L-Ala-L-Pro and L-carnosine (/3-alanyl-L-histidine) 
164 l. Naasani et al. / Biochimica et Biophysica Acta 1231 (1995) 163-168 
COOH H CH 3 
lot 
COOH 
L-carnoslne L-Ala-L-Pro 
o 
s 
H aN ~'~'CH a H 
COOH 
COOH 
Ceftlbuten 
Fig. 1. Structures ofceftibuten. L-AIa-L-Pro and L-carnosine. 
were purchased from Sigma (St. Louis, MO, USA) and 
Fluka (Buchs, Switzerland), respectively. All other chemi- 
cals were of the highest grade available and used without 
further purification. The structures of ceftibuten, L-Ala-L- 
Pro and L-carnosine are shown in Fig. 1. 
2,2. Preparation of  the brush-border membrane vesicles 
Male Wistar rats (200-250 g) were used for the isola- 
tion of membrane vesicles and all the procedures were 
carried out at 4°C. The small intestinal brush-border mem- 
brane vesicles were prepared by the Ca 2+ precipitation 
method according to the method of Kessler et al. [7] with 
minor modifications as described previously [8]. The renal 
brush-border membrane vesicles were isolated from the 
renal cortex by the Mg2+/EGTA precipitation method of 
Biber et al. [9] with several modifications. Briefly, cortex 
slices were homogenized with a Waring blender (Nihon 
Seiki, Japan) at 16500 rpm for 4.5 min in an appropriate 
volume of a homogenizing buffer composed of 300 mM 
mannitol, 12 mM Tris-HC1 (pH 7.1) and 5 mM EGTA. 
Then, the homogenate was diluted with distilled water 
(1:1) and MgC12 was added to a final concentration of 10 
raM. After 15 rain, the mixture was centrifuged at 19000 
× g for 15 rain. The supernatant was then centrifuged at 
27000 × g for 30 rain. An appropriate volume of the 
homogenizing buffer was diluted with distilled water ( l : l )  
and used to resuspend the resulting pellets. Then, the pellet 
suspension was Homogenized in a Dounce-type homoge- 
nizer (10 strokes). MgCI 2 was added to a final concentra- 
tion of 10 mM and the first two steps of centrifugation 
were repeated once more. The resulting pellets were washed 
once with the experimental buffer. The washing was done 
by homogenizing in a Dounce-type homogenizer (10 
strokes) and then centrifugation at 27 000 × g for 30 min. 
The final pellets were resuspended in the experimental 
buffer using a Dounce-type homogenizer to give a final 
protein concentration of 10-15 mg/ml. Similar protein 
concentration was adopted for the intestinal brush-border 
membrane vesicles. Unless otherwise specified, the experi- 
mental buffer was comprised of 100 mM mannitol, 100 
mM KC1 and 10 mM Hepes-Tris (pH 7.5). Enrichment of 
the brush-border membrane fraction, was 10-fold com- 
pared to the homogenate as revealed from the assessment 
of specific activity of the membrane enzyme marker, alka- 
line phosphatase. Uptake experiments of tetraethyl- 
ammonium (TEA+), (a typical substrate for the cation 
transport system) and of D-[CI4]glucose, revealed a func- 
tional integrity of the renal and the intestinal membrane 
preparations, respectively. 
2.3. Uptake experiments 
The uptake of ceftibuten into the freshly isolated mem- 
brane vesicles was performed at 25°C by the rapid filtra- 
tion technique according to the method of Sugawara et al., 
[10] with minor modification. The reaction was initiated by 
mixing of 40 /al of membrane vesicle suspension with 200 
/al of the transport buffer (unless stated otherwise, the 
transport buffer was composed of 100 mM D-mannitol 100 
mM KC1, 20 mM Mes-Tris, pH 5.5) containing substrates. 
Then, at the stated times, the reaction was terminated by 
diluting the reaction mixture with 4 ml of the ice-cold stop 
buffer (150 mM NaC1, 20 mM Hepes-Tris, pH 7.5) fol- 
lowed by filtration through a Millipore filter (HAWP, 0.45 
/am, 2.5 cm diam.). The filter was then washed once with 
8 ml of the ice-cold stop buffer. Ceftibuten trapped on the 
filter was extracted with 300 /xl of the stop buffer. 
2.4. Analytical procedures 
The detection of ceftibuten was carried out by the use 
of high-performance liquid chromatography as described 
previously [4,5,10,11]. Separation of ceftibuten was 
achieved on a reverse-phase column (ODS Hitachi #3053, 
5 /am, 4 mm i.d. × 250 mm) using a mobile phase consist- 
ing of acetonitrile/0.05 M citric acid-0.1 M KC1 buffer, 
pH 2.5 (1:9). Samples were eluted at a flow rate of 0.7 
ml/min, and the detection was set at 262 nm. Protein was 
measured by the method of Lowry et al. [12] with bovine 
serum albumin as standard. 
3. Results 
3.1. Comparison of  the concentration dependency and the 
kinetics of  ceftibuten transport in the renal and intestinal 
brush-border membrane t,esicles 
The effect of increasing concentration of ceftibuten on 
its uptake in the presence of an inwardly directed H + 
gradient was investigated in both of the renal and the 
intestinal brush-border membrane preparations. The 30-s 
uptake rates were determined by measuring ceftibuten 
uptake with a range of concentrations from 50 /aM to 20 
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Fig. 2. Concentration dependency of ceftibuten i itial (30 s) uptake by rat 
renal brush-border membrane vesicles in the presence of an inwardly 
directed H + gradient (pHin 7.5, pHo, t 5.5). Ceftibuten concentration was 
varied over the range of 0.05-20 mM. Values are the mean+S.D, of 
eight determinations from two different preparations. Inset represents he 
Eadie-Hofstee plot with its components (dotted lines). 
mM. Fig. 2 and Fig. 3 illustrate that the uptake was 
saturable as a function of concentration. The Eadie-Hofs- 
tee plot of the uptake into the renal bush-border membrane 
vesicles (inset of Fig. 2) reveals the presence of at least 
two transport components characterized asthe high affinity 
low capacity system and the low affinity high capacity 
system. On the other hand, the Eadie-Hofstee plot of the 
uptake into the intestinal brush-border membrane vesicles 
(inset of Fig. 3) reveals a monocomponent transport sys- 
tem. The presence of a different number of transport 
systems between the renal and the intestinal brush-border 
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Table 1 
Apparent kinetic parameters of ceftibuten i itial (30 s) uptake by rat renal 
and intestinal brush-border membrane vesicles 
Parameter Kidney ~ Intestine 
HA LA 
Vma x (pmol/mg protein per 30 s) 105 1400 1701 
K,~ (/zM) 26 1950 425 
K 0 (pmol/mg protein per 30 s per mM) 85 95 
a HA and LA refer to the high and low affinity transport systems, 
respectively. 
membranes i also evident from the non-linear egression 
analysis and least-squares fitting, where, the best fitting for 
the uptake by the renal brush-border membrane vesicles 
was attainable when a double Michaelis-Menten model 
with non-saturable component (simple diffusion) was 
applied (see Eq. (1)). On the other hand, the best fitting for 
the uptake by the intestinal brush-border membrane vesi- 
cles was achieved with a normal Michaelis-Menten model 
with non-saturable component (see Eq. (2)). The kinetic 
constants of the transport systems are summarized in Table 
1. 
Vm., [s] Vmax [S] 
V= Km,[S~--- T + Km2 [S~-~"Kd [S] ( | )  
Vmax 
V =Km [s-----~ + Kd [s] (2) 
where: V is the initial uptake rate, [s] is the initial substrate 
concentration, K d is the constant of the non-saturable 
component, K m is the affinity constant, Vma x is the maxi- 
mum uptake rate 
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Fig. 3. Concentration dependency of ceftibuten i itial (30 s) uptake by rat 
intestinal brush-border membrane vesicles in the presence of an inwardly 
directed H + gradient (pHin 7.5, pHou t 5.5). Ceftibuten concentration was 
varied over the range of 0.05-20 mM. Values are the mean+S.D, of 
seven determinations from two different preparations. Inset represents he 
Eadie-Hofstee plot with its components (dotted lines). 
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Fig. 4. Dixon plot analysis of ceftibuten initial (30 s) uptake by rat renal 
brush-border membrane vesicles at a low range of substrate concentra- 
tions in the presence of L-AIa-L-Pro and an inwardly directed H + 
gradient (pHin 7.5, pHou t 5.5). The inset shows a replot of the slopes of 
Dixon plot. Values are the mean of four measurements. 
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Fig. 5. Dixon plot analysis of ceftibuten initial (30 s) uptake by rat renal 
brush-border membrane vesicles at a high range of substrate concentra- 
tions in the presence of L-AIa-L-Pro and an inwardly directed H + 
gradient (pHi, ' 7.5, pHou ~ 5.5). The inset shows a replot of the slopes of 
Dixon plot. Values are the mean of four measurements. 
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Fig. 7. The ineffectiveness of L-carnosine in inhibiting the uptake of 
ceftibuten by rat renal brush-border membrane vesicles at a high range of 
substrate concentrations and in the presence of an inwardly directed H + 
gradient (pHin 7.5, pHou ~ 5.5), The data are plotted as Dixon plot. Values 
are the mean of four measurements. 
3.2. Dixon plot analysis in the presence of dipeptides and 
an inwardly directed H + gradient 
In the presence of L-A/a-L-Pro 
In a previous study [1 I], the inhibitory effect of L-Ala- 
L-Pro on the uptake of ceftibuten by rat intestinal brush- 
border membrane vesicles has been investigated by Dixon 
plot analysis. The results of this analysis have demon- 
strated that the uptake of ceftibuten was inhibited by 
L-Ala-L-Pro in a non-competitive manner with an apparent 
K a value of 1.21 raM. In the case of the renal brush-border 
membrane, the presence of two transport systems with 
different affinities and capacities addresses the requirement 
of carrying out the Dixon plot analysis at two different 
ranges of substrate concentrations in order to accommo- 
date the operational capacity of each transporter. Accord- 
ingly, the 30-s uptake values of ceftibuten at a range of 
concentrations from 50 /~M to 200 /~M or from 750 /~M 
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Fig. 6. Dixon plot analysis of ceftibuten initial (30 s) uptake by rat renal 
brush-border membrane vesicles at a low range of substrate concentra- 
tions in the presence of L-carnosine and an inwardly directed H + gradient 
(pHin 7.5, pH,,ut 5.5). The inset shows a replot of the slopes of Dixon 
plot. Values are the mean of four measurements. 
to 3 mM were plotted as Dixon analysis in the presence of 
increasing concentrations of L-Ala-L-Pro (Fig. 4 and Fig. 
5). The kinetics of the inhibition at low substrate concen- 
trations (Fig. 4) are consistent with a partially competitive 
inhibition. Meanwhile, the kinetics of the inhibition at a 
high range of substrate concentrations (Fig. 5) are clearly 
in agreement with a competitive type of inhibition because 
the replot of the slope of Dixon plot almost coincided with 
the origin in contrast o that at low substrate concentra- 
tions. 
In the presence (?f L-carnosine 
Based on an earlier study [10], it was reported that 
L-carnosine does not affect the uptake of ceftibuten by rat 
intestinal brush-border membrane vesicles in anyway. On 
the contrary, we have recently reported that L-carnosine is 
effective in inhibiting the uptake of ceftibuten by rat renal 
brush-border membrane vesicles [6]. To further examine 
these effects, as in the above studies with L-Ala-L-Pro, 
Dixon analysis of the 30 s uptake of ceftibuten in the 
presence of L-carnosine was carried out at two different 
levels of substrate concentrations. Fig. 6 illustrates that at 
low substrate concentrations, L-carnosine xhibited a typi- 
cal competitive inhibition on the uptake of ceftibuten. 
Surprisingly, as shown in Fig. 7, L-camosine did not 
exhibit any inhibitory effect when a high level of substrate 
concentrations was used. 
4. Discussion 
The results of the present study provided further details 
on the transport mechanism of ceftibuten in particular and 
oligopeptides in general across the brush-border mem- 
branes. The uptake of ceftibuten by the renal brush-border 
membrane vesicles appeared to be mediated by two carrier 
systems with different affinities and capacities. The possi- 
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bility that the high affinity low capacity system is nothing 
more than a binding artifact is excluded because the uptake 
rates at low temperature (4°C) were very small and unsat- 
urable (data not shown). In our previous work [6], we have 
demonstrated that the transport of ceftibuten in rat renal 
brush-border membrane is mediated, at least in part, by a 
common transport mechanism with oligopeptides. Since 
the renal brush-border membrane is well furnished with 
several types of anion transporters [13], one of the trans- 
port systems for ceftibuten across this membrane could be 
merely a result of the interference from the anion trans- 
porters. However, based on our previous study [6], this is 
unlikely because the transport of ceftibuten in the renal 
brush-border membrane was found to be independent of 
Na + ions and all types of organic acids (mono-and icar- 
boxylate) have not had any inhibitory effect. The in- 
hibitory effect of L-Ala-L-Pro on each of the transport 
systems of ceftibuten in the renal brush-border membrane 
provided an evident hat both of the ceftibuten transporters 
were common transporters for oligopeptides. This is fur- 
ther supported by the results of Silbernagl et al. [14], 
Daniel et al. [15] and Skopicki et al. [16], where, it has 
been shown that the oligopeptides transport in the rat renal 
brush-border membrane is mediated by two transport sys- 
tems with different affinities and capacities. Concerning 
the intestinal transport, the present study revealed that the 
transport of ceftibuten is mediated by one transport system. 
The specificity and the type of inhibition induced by 
dipeptides on this transport system were not always similar 
to those for the transport systems in the renal brush-border 
membrane. The differences are summarized in Table 2. 
The effect of L-Ala-L-Pro on the transport in the renal 
brush-border membrane was partially competitive and 
competitive for the high and the low affinity systems, 
respectively. Whereas, it has been found that this dipeptide 
is a non-competitive inhibitor for the transport in the 
intestinal brush-border membrane [l 1]. Interestingly, L- 
carnosine, which is in the cationic form at pH 5.5, had the 
potential to inhibit only the high affinity system in the 
renal brush-border membrane; however, it had no effect on 
the low affinity system of the kidney and on the transport 
system of the intestine as well. The failure of L-carnosine 
in inhibiting the low affinity transport system of the kidney 
and the transport system of the intestine indicates that the 
Table 2 
Types  and constants b o f  inhibit ion induced by L-AIa-L-Pro and L-carno- 
sine on the uptake of  cef i ibuten into rat renal and intestinal brush-border  
membrane  vesic les 
Transport system L-AIa-L-Pro L-Carnosine 
HA Partially competitive, Competitive, 
K i = 120 K i = 250 
Kidney 
LA Compet i t ive ,  K i = 520 No  inhibit ion 
Intest ine a Non-compet i t ive ,  K i = 1210 No  inhibit ion 
a Reported in Ref. [11]. h Units in p~M. 
substrate binding sites of these systems are positively 
charged. This assumption is further supported by the stud- 
ies with histidyl or thiol group-specific agents [17-19]. 
These studies have shown that histidyl groups are involved 
in the transport of dipeptides in both the renal and the 
intestinal brush-border membranes. However, when thiol 
group-specific agents were used, only the renal transport of 
dipeptides was affected. It is likely that the substrate 
binding site of the high affinity transport system in the 
kidney consists mainly of neutral groups (such as thiol 
groups) that permit the dual transport of positively or 
negatively charged substrates. The existence of the same 
carrier protein for oligopeptides in the intestine and kidney 
has been recently referred by Fel et al. [20]. This group has 
succeeded in cloning the expression of a putative carrier 
protein for oligopeptides in the small intestine, kidney, 
liver and brain of the rabbit. From this finding, collectively 
with the results of the present study, it seems that the low 
affinity transporter in the renal brush-border membrane 
and the transporter in the intestinal brush-border mem- 
brane are of similar features and the differences noticed 
between these two types of brush-border membranes are 
due to the presence of an extra high affinity transport 
system in the renal brush-border membrane. Finally, it is 
worth noting that the existence of such a high affinity 
system for the transport of ceftibuten in the renal brush- 
border membrane (in the reabsorptive direction across the 
proximal tubular cell) is of pharmacological importance 
because it provides an explanation for the relatively long 
elimination half-life and for the specific effect of this 
antibiotic on the renal infections. 
References 
[1] Wiseman, L.R. and Balfour, J.A. (1994) Drugs 47 (5), 784-808. 
[2] Muranushi, N., Yoshikawa, T., Yoshida, M., Ogumo, T., Hirano, K. 
and Yamada, H. (1989) Pharm. Res. 6, 308-312. 
[3] Yoshikawa, T., Muranushi, N., Yoshida, M., Oguma, T., Hirano, K. 
and Yamada, H. (1989) Pharm. Res. 6, 302-307 
[4] Sugawara, M., Iseki, K. and Miyazaki, K. (1991) J. Pharm. Pharma- 
col. 43, 433-435. 
[5] Sugawara, M., Iseki, K., Miyazaki, K., Shiroto, H., Kondo, Y. and 
Uchino, J.-I. (1991) J. Pharm. Pharmacol. 43, 882-884. 
[6] Naasani, I., Sugawara, M., Kobayashi, M., Iseki, K. and Miyazaki, 
K. (1995) Pharm. Res. 12, 605-608. 
[7] Kessler, M., Acuto, O., Strelli, H., Murer, M. and Semenza, G. 
(1978) Biochim. Biophys. Acta 506, 136-154. 
[8] Iseki, K., Sugawara, M., Saito, H., Miyazaki, K. and Arita, T. 
(1989) J. Pharm. Pharmacol. 41,628-632. 
[9] Biber, J., Stieger, B., Haase, H. and Murer, H. (1981) Biochim. 
Biophys. Acta 647, 169-176. 
[10] Sugawara, M., Toda, T., Iseki, K., Miyazaki, K., Shiroto, H., 
Kondo, Y. and Uchino, U. (1992) J. Pharm. Pharmacol. 44, 968-972. 
[11] Sugawara, M., Toda, T., Kobayashi, M., Iseki, K., Miyazaki, K., 
Shiroto, H., Kondo, Y. and Uchino, J.-I. (1994) J. Pharm. Pharma- 
col. 46, 680-684. 
[12] Lowry, O.H., Rosebrough, N.J., Fan-, A.L. and Randall, R.J. (1951) 
J. Biol. Chem. 193, 265-275. 
[13] Ullrich, K.J. (1994) Biochim. Biophys. Acta 1197, 45-62. 
168 1. Naasani et al. / Biochimica et Biophysica Acre 1231 (1995) 163-168 
[14] Silbernagl, S., Ganapathy, V. and Leibach, F.H. (1987) Am. J. 
Physiol. 253, F448-F457. 
[15] Daniel, H., Morse, L.E. and Adibi, S.A. (1991) J. Biol. Chem. 266, 
19917-19924. 
[16] Skopicki, H.A., Fisher, K., Zikos, D., BIoch, R., Flouret, G. and 
Peters, D.R. (1991) Am. J. Physiol. 261, F670-F678. 
[17] Miyamoto, Y., Ganapathy, V. and Leibach, F.H. (1986) J. Biol. 
Chem. 261, 16133-16140. 
[18] Miyamoto, Y., Tiruppathi, C., Ganapathy, V. and Leibach, F.H. 
(1989) Biochim. Biophys. Acta. 978, 25-31. 
[19] Kramer, W., Durckheimer, W., Girbig, F., Gutjahr, U., Leipe, I. and 
Oekonomopulos, R. (1990)Biochim. Biophys. Acta 1028, 174-182. 
[20] Fel, Y.-J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F.H., 
Romero, M.F., Singh, S.K., Boron, W.F. and Hediger, M.A. (1994) 
Nature 368, 563-566. 
